Lifetime history of an anxiety or depression disorder and adherence to medications used for the acute treatment of migraine

In this secondary analysis of mobile health headache diary data, we evaluated the relationship between adherence to medication used for the acute treatment of migraine and lifetime history of an anxiety or depression disorder.

[1]  N. Murinova,et al.  Patient-Centered Treatment of Chronic Migraine With Medication Overuse , 2022, Neurology.

[2]  R. Burch,et al.  The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice , 2021, Headache.

[3]  T. Wijeratne,et al.  The Prevalence of Migraine With Anxiety Among Genders , 2020, Frontiers in Neurology.

[4]  Yaxin Zhang,et al.  Depression and cardiovascular disease in elderly: Current understanding , 2018, Journal of Clinical Neuroscience.

[5]  M. Arnold.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.

[6]  M. Robbins,et al.  Acute migraine medication adherence, migraine disability and patient satisfaction: A naturalistic daily diary study , 2017, Cephalalgia : an international journal of headache.

[7]  H. Diener,et al.  Medication-overuse headache: risk factors, pathophysiology and management , 2016, Nature Reviews Neurology.

[8]  A. Steptoe,et al.  Psychosocial Factors in Diabetes and Cardiovascular Risk , 2016, Current Cardiology Reports.

[9]  R. Lipton,et al.  Migraine and its psychiatric comorbidities , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  R. Spengler,et al.  The hippocampus and TNF: Common links between chronic pain and depression , 2015, Neuroscience & Biobehavioral Reviews.

[11]  S. Silberstein,et al.  The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies , 2015, Headache.

[12]  D. Finn,et al.  Neuroinflammatory Mechanisms Linking Pain and Depression. , 2015, Modern trends in pharmacopsychiatry.

[13]  C. Lundqvist,et al.  Medication-overuse headache: epidemiology, diagnosis and treatment , 2014, Therapeutic advances in drug safety.

[14]  S. Landy,et al.  A Cross‐Sectional Survey to Assess the Migraineur's Medication Decision‐Making Beliefs: Determining When a Migraine Is Triptan‐Worthy , 2013, Headache.

[15]  R. Ohrbach,et al.  The International Classification of Headache Disorders, 3rd edition (beta version) , 2013, Cephalalgia : an international journal of headache.

[16]  P. Cortelli,et al.  Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study , 2013, The Journal of Headache and Pain.

[17]  R. Lipton,et al.  Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study , 2012, Headache.

[18]  T. Steiner,et al.  Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Trøndelag Health Studies , 2012, PAIN.

[19]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[20]  Jerry L. Grenard,et al.  Depression and Medication Adherence in the Treatment of Chronic Diseases in the United States: A Meta-Analysis , 2011, Journal of General Internal Medicine.

[21]  Mustafa Karakus,et al.  Depression and the Onset of Chronic Illness in Older Adults: A 12-Year Prospective Study , 2011, The Journal of Behavioral Health Services & Research.

[22]  M. Sevick,et al.  Self-monitoring in weight loss: a systematic review of the literature. , 2011, Journal of the American Dietetic Association.

[23]  S. Krause,et al.  Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter? , 2010, Headache.

[24]  N. Sethi.  EXCESSIVE ACUTE MIGRAINE MEDICATION USE AND MIGRAINE PROGRESSION , 2009, Neurology.

[25]  R. Lipton,et al.  Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. , 2009, Mayo Clinic proceedings.

[26]  M. Maizels,et al.  Predictors of Adherence to Triptans: Factors of Sustained vs Lapsed Users , 2009, Headache.

[27]  R. Lipton,et al.  Excessive acute migraine medication use and migraine progression , 2008, Neurology.

[28]  Mark A Pereira,et al.  The Impact of Regular Self-weighing on Weight Management: A Systematic Literature Review , 2008, The international journal of behavioral nutrition and physical activity.

[29]  W. Stewart,et al.  Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study , 2008, Headache.

[30]  S. Silberstein,et al.  Cephalalgiaphobia: a possible specific phobia of illness , 2007, The Journal of Headache and Pain.

[31]  R. Lipton,et al.  Migraine prevalence, disease burden, and the need for preventive therapy , 2007, Neurology.

[32]  D. Penzien,et al.  Behavioral Facilitation of Medical Treatment for Headache—Part I: Review of Headache Treatment Compliance , 2006, Headache.

[33]  M. Lanteri-Minet,et al.  Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management , 2005, Pain.

[34]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[35]  R. Cady,et al.  Treating Early Versus Treating Mild: Timing of Migraine Prescription Medications Among Patients With Diagnosed Migraine , 2005, Headache.

[36]  L. Bouter,et al.  Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. , 2005, The Cochrane database of systematic reviews.

[37]  R. Gallagher,et al.  Migraine Medication Attributes Important for Patient Compliance: Concerns About Side Effects May Delay Treatment , 2003, Headache.

[38]  F. Radat.  Migraine et comorbidité psychiatrique , 2005 .

[39]  J. Dunbar-Jacob,et al.  Treatment adherence in chronic disease. , 2001, Journal of clinical epidemiology.

[40]  Jennifer Y. Liu,et al.  Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.

[41]  P. McGrath,et al.  Decision Making in Migraine Patients Taking Sumatriptan: An Exploratory Study , 2000, Headache.

[42]  O. Bruni,et al.  Headache and Psychiatric Comorbidity: Clinical Aspects and Outcome in an 8-Year Follow-Up Study , 1998, Cephalalgia : an international journal of headache.

[43]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[44]  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. , 1988, Cephalalgia : an international journal of headache.